Clinical Trials List
Protocol NumberCABL001J12301
2021-12-01 - 2029-05-10
Phase III
Recruiting2
Terminated1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ming-Yu Lien 無
- Chi-Ching Chen 無
- Tzu-Ting Chen 無
- 王秀慈 無
- Che-Hung Lin 無
- 鄭富銘 無
- Ching-Chan Lin 無
- Ming-Hung Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSUAN JEN SHIH 無
- 高小雯 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8-20 participants
-
Global
402 participants
